Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aim, Anixa, Baudaxbio, Celcuity, Clinigen, Compass, Createrna, Daiichi Sankyo, Design, Diamond, Dragonfly, Federation, Horizon, Ionctura, Kronos, Novadip, Phavaris, Regenxbio, Spago, Spinethera.